Publication

Efficacy and safety of the LSD1 inhibitor bomedemstat in participants with polycythemia vera (PV) resistant or intolerant to cytoreductive therapy: The Phase 2 shorespan-004 study

Rein, Lindsay
Livings, Alice
Innes, Andrew
Mahdi, Ali
Rinaldi, Ciro
Curto-Garcia, Natalia
Vaughn, Jennifer
Shatzel, Joseph
Yeh, Paul
... show 4 more
Glos Author
Date
2025-12-05
Journal Title
Type
Conference Abstract
Engagement
Google Scholar:
Altmetric:
Collections
Abstract
No abstract available
Citation
Rein et al (2025). Efficacy and safety of the LSD1 inhibitor bomedemstat in participants with polycythemia vera (PV) resistant or intolerant to cytoreductive therapy: The Phase 2 shorespan-004 study. Blood, 146, 83.
Registration number
License
Free access to article on publisher's webpage. Click DOI.
Usage rights
Free access to article on publisher's webpage. Click DOI.
License